What Is a GLP-1? Semaglutide, Tirzepatide, and Why the Name on the Box Decides What You Pay

Watch instead

The short version

GLP-1 is a hormone your gut releases after you eat. It tells your pancreas to send insulin, slows your stomach down, and tells your brain you've had enough. Natural GLP-1 is gone in about two minutes, which is why it could never be a medicine on its own. So chemists rebuilt it to last a week. Semaglutide gets sold under one name for diabetes and another for weight loss - same molecule, two labels. Tirzepatide is split the same way.

Key points

GLP-1 is a hormone you already make. The drugs are engineered copies that last days instead of minutes.
Semaglutide is sold under one name for diabetes and a different one for weight loss. Tirzepatide too. Same molecule, different label.
Tirzepatide hits a second gut hormone receptor too, and in head-to-head studies produced more weight loss.
Insurance follows the label, not the molecule, which is the single most common reason people get told no.
When people stop, most of the weight comes back. That's physiology doing its job, not a character flaw.

Everybody is saying these words and nobody is defining them

GLP-1. Semaglutide. Tirzepatide. Plus a handful of brand names you have heard on television.

That is a pile of words for what is basically two drugs, and the confusion is not an accident of language. It costs people real money. Let's clear it up.

There was a hormone before there was a drug

Your small intestine has cells whose whole job is noticing when food shows up. When it does, they release glucagon-like peptide-1 into your bloodstream.

It does several things at once. It tells your pancreas to release insulin, but only when blood sugar is already up, which is why it doesn't usually drive sugar dangerously low on its own. It tells your liver to quit dumping stored sugar. It slows how fast your stomach empties. And it talks to the parts of your brain that handle appetite and reward, producing that feeling of having had enough.

This happens after every meal, in every healthy body, and then it stops. Natural GLP-1 gets destroyed in about two minutes by an enzyme called DPP-4.

That two minutes is the entire reason the hormone itself could never be a medicine.

What the chemists actually did

Making GLP-1 useful meant making it last.

So they changed the amino acid at the exact spot where that enzyme attacks, so it can't cut anymore. Then they hung a fatty acid chain on the molecule so it clings to albumin, a carrier protein already floating in your blood. The albumin acts like a slow-release reservoir.

Result: something that behaves like the natural hormone at the receptor but sticks around about a week instead of two minutes. That's why these are weekly shots. Earlier ones in the family, like liraglutide, were engineered less aggressively and are daily.

Tirzepatide goes a step further. It activates the GLP-1 receptor and also the receptor for GIP, a second gut hormone that comes out after you eat. Exactly why hitting both does more is still being worked out, but head-to-head against semaglutide it produced more weight loss on average.

There's also an oral semaglutide, taken daily with a list of strict instructions, because only a small fraction of a swallowed dose survives the trip.

Sorting the names out, because this one costs money

Semaglutide is sold under one name approved for type 2 diabetes and a second name approved for weight management. Same molecule. Different maximum doses, different labels. The oral semaglutide tablet gets a third name of its own.

Tirzepatide does the same trick. One name approved for type 2 diabetes, another approved for weight management, and that second one also picked up an approval for moderate-to-severe obstructive sleep apnea in adults with obesity.

Liraglutide, the older daily one, splits the same way: one name for diabetes, one for weight. There are others.

Now here's why any of that matters to you. Insurance coverage usually follows the approved indication on the label, not the molecule in the pen. A plan will happily cover a GLP-1 prescribed for diabetes and flatly refuse the identical molecule prescribed for weight.

That is not a medical judgment about you. It's a benefit design decision made in a room you'll never see, and it is the single most common reason people get told no.

A woman walking her dog on a neighborhood sidewalk at golden hour

What they actually do for people

For type 2 diabetes, they lower blood sugar reliably, and unlike some older options they tend to take weight off rather than put it on. Several in the class have also been shown in large cardiovascular outcome trials to reduce the risk of major cardiac events in people with type 2 diabetes and established heart disease.

For weight, the results genuinely changed what people thought medication could do. In the main semaglutide weight-management trials, adults without diabetes lost on the order of 15 percent of their starting body weight on average over roughly 68 weeks, alongside lifestyle counseling. In the main tirzepatide trial, average loss at the highest dose landed somewhere around 20 percent over about 72 weeks.

Averages hide a lot. Some people lost far more. Some lost very little. People with type 2 diabetes generally lose less than people without it.

And a large randomized trial in people with overweight or obesity and established cardiovascular disease but no diabetes found semaglutide reduced major cardiovascular events compared with placebo. That one shifted the whole conversation, because it suggested the benefit isn't only about the number on the scale.

Which tracks with what people actually tell each other. Not pants sizes. Stairs. Sleeping through the night. A day where the knees don't file a complaint.

What happens when you stop

This deserves more airtime than it gets, so here it is plainly. In studies where people came off, most regained a large share of what they lost. Blood sugar and cardiovascular markers drifted back toward where they started.

That is not the drug failing, and it is absolutely not you failing.

The medication was supplying a signal your body wasn't supplying on its own. Take the signal away and the old set point reasserts itself, and it does so with real physiological machinery behind it, because your body defends its weight like it's defending your life.

The practical upshot is that these are being used the way blood pressure medication is used. Long-term management of a chronic condition, not a course with an end date.

That reframe matters for planning, for cost, and for how you talk to yourself if you go back on after a gap.

A bowl of oatmeal and a glass of water on a kitchen counter

Who these are not for

The class carries a boxed warning about thyroid C-cell tumors seen in rodents, and it's off the table for anyone with a personal or family history of medullary thyroid carcinoma or the genetic syndrome MEN 2.

Not recommended in pregnancy. A history of pancreatitis, gastroparesis, certain gut conditions, or active gallbladder disease needs a real conversation, not a form. If you take insulin or sulfonylureas, those may need adjusting so your sugar doesn't bottom out.

Only somebody who knows your history can weigh this. What you can do is walk in knowing which questions to ask, and knowing that the name they write on the script may decide whether you can afford it.

And the part I'm not skipping

I've watched people carry shame about their bodies into rooms where they were supposed to find rest. If that's you, hear this: needing help is not a character defect, and taking care of the one body you were given is stewardship, not vanity.

Nobody gets extra credit for suffering through something quietly.

Pray about it. Then take it to a real prescriber who knows your history, not a blog, not mine.

And then come tell us how the conversation went. That's the part that helps the next person.

Trust God. Be committed. Stay informed.

Common questions

Is the diabetes version the same drug as the weight-loss version?

Same molecule, semaglutide, sold under two labels for two approved purposes at different maximum doses. Your insurance almost certainly treats them as two different things, which is the whole reason this confusion exists.

Is tirzepatide a GLP-1?

Sort of, and more. Tirzepatide hits the GLP-1 receptor and also the GIP receptor. People call it a GLP-1 as shorthand. And like semaglutide, it is sold under one name for diabetes and another for weight.

Do these work if I don't change how I eat?

They reduce appetite, so eating usually changes on its own whether or not you planned it. But every trial paired them with lifestyle support, and the people who protect their protein and keep lifting hold onto far more of their strength. That part is not optional if you want to still be able to get off the floor at eighty.

How long do you have to stay on one?

The honest answer is that they're being used as long-term management, like blood pressure medicine, because the effect depends on the signal still being there. Anybody promising you a tidy finish line is guessing.

Is there a pill version?

There's an oral semaglutide, taken daily with strict instructions about an empty stomach, because only a small fraction of a swallowed dose survives digestion. It exists because getting a peptide past your stomach is genuinely hard, not because anybody was being difficult.

See the research

Want the published studies behind this? Peptide Proof is an independent site that summarizes the research in plain English.

Come tell us how it's going

This is the part that actually matters. Real people, honest questions, nobody selling you anything.

Join The Well →Chat with someone directly

Or get new posts by email. Three a week, that's it. Unsubscribe any time.